Short communication: Immunological assessment of plant-derived avian flu H5/HA1 variants

Polypeptide variants of the HA1 antigenic domain of the H5N1 avian influenza virus hemagglutinin (HA) molecule were produced in plants using transient and stable expression systems and fused with His/c-myc tags or with mouse or human Fc antibody fragments. The resulting peptides were purified and us...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2009-02, Vol.27 (9), p.1289-1292
Main Authors: Spitsin, S, Andrianov, V, Pogrebnyak, N, Smirnov, Y, Borisjuk, N, Portocarrero, C, Veguilla, V, Koprowski, H, Golovkin, M
Format: Article
Language:English
Subjects:
Avian influenza virus
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Polypeptide variants of the HA1 antigenic domain of the H5N1 avian influenza virus hemagglutinin (HA) molecule were produced in plants using transient and stable expression systems and fused with His/c-myc tags or with mouse or human Fc antibody fragments. The resulting peptides were purified and used for intramuscular immunization of mice. While the recombinant HA1 variants induced a significant serum humoral immune response in the mice, none of the HA1 preparations induced virus-neutralizing antibodies. Fusion with the Fc fragment improved overall yield of the constructs and allowed purification requiring only a single step, but led to no detectable fusion-related enhancement of immunogenicity or quality of immune response.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2008.12.050